Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gabriella d'Ettorre and Giancarlo Ceccarelli.
Gabriella d'Ettorre
Connection Strength
10.809
Giancarlo Ceccarelli
  1. Oxygen Sparing Effect of Bacteriotherapy in COVID-19. Nutrients. 2021 Aug 23; 13(8).
    View in: PubMed
    Score: 0.963
  2. Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study. Front Nutr. 2020; 7:613928.
    View in: PubMed
    Score: 0.923
  3. Is previous influenza-like illness a potential Trojan horse for COVID-19? Crit Care. 2020 08 14; 24(1):503.
    View in: PubMed
    Score: 0.897
  4. Probiotics and COVID-19. Lancet Gastroenterol Hepatol. 2020 08; 5(8):721-722.
    View in: PubMed
    Score: 0.895
  5. Clearance of human papillomavirus related anal condylomas after oral and endorectal multistrain probiotic supplementation in an HIV positive male: A case report. Medicine (Baltimore). 2018 Apr; 97(16):e0329.
    View in: PubMed
    Score: 0.761
  6. Single-strain versus multistrain probiotic supplementation treatment strategy for rheumatoid arthritis: comment on the article by Marietta et al. Arthritis Rheumatol. 2018 02; 70(2):320-321.
    View in: PubMed
    Score: 0.746
  7. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals. Nutrients. 2017 Nov 21; 9(11).
    View in: PubMed
    Score: 0.743
  8. Clinical Characteristics and Outcome of Patients with Suspected COVID-19 in Emergency Department (RESILIENCY Study II). Diagnostics (Basel). 2021 Jul 29; 11(8).
    View in: PubMed
    Score: 0.240
  9. Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 age. J Med Virol. 2021 Jul; 93(7):4399-4404.
    View in: PubMed
    Score: 0.235
  10. Post-traumatic Stress Disorder Among COVID-19 Survivors at 3-Month Follow-up After Hospital Discharge. J Gen Intern Med. 2021 06; 36(6):1702-1707.
    View in: PubMed
    Score: 0.234
  11. The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study). J Med Virol. 2021 Jul; 93(7):4319-4325.
    View in: PubMed
    Score: 0.234
  12. Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection. Chemotherapy. 2021; 66(1-2):24-32.
    View in: PubMed
    Score: 0.234
  13. Surveillance of COVID-19 in migrant reception centres: a call for action. J Travel Med. 2021 02 23; 28(2).
    View in: PubMed
    Score: 0.233
  14. Dysbiosis in SARS-CoV-2-Infected Patients. Gastroenterology. 2021 05; 160(6):2195.
    View in: PubMed
    Score: 0.230
  15. Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Eur J Clin Invest. 2021 Jan; 51(1):e13418.
    View in: PubMed
    Score: 0.227
  16. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report. Medicine (Baltimore). 2020 Sep 04; 99(36):e21803.
    View in: PubMed
    Score: 0.225
  17. Preventing influenza and influenza like illness during Covid-19 pandemic: A call for action. Early Hum Dev. 2020 Aug 12; 105156.
    View in: PubMed
    Score: 0.224
  18. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med (Lausanne). 2020; 7:389.
    View in: PubMed
    Score: 0.223
  19. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review. Nutrients. 2020 Jun 08; 12(6).
    View in: PubMed
    Score: 0.222
  20. Is teicoplanin a complementary treatment option for COVID-19? The question remains. Int J Antimicrob Agents. 2020 Aug; 56(2):106029.
    View in: PubMed
    Score: 0.221
  21. Impact of the 2017 measles outbreak on the emergency care system of a large tertiary-care teaching hospital in Italy: a retrospective analysis. Eur J Public Health. 2019 10 01; 29(5):966-971.
    View in: PubMed
    Score: 0.211
  22. Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects. Microorganisms. 2019 Jun 03; 7(6).
    View in: PubMed
    Score: 0.206
  23. Increased IL-17 and/or IFN-? producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women. AIDS. 2019 03 15; 33(4):627-636.
    View in: PubMed
    Score: 0.203
  24. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients. Clin Res Hepatol Gastroenterol. 2018 09; 42(4):319-329.
    View in: PubMed
    Score: 0.187
  25. Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach. Int J Tryptophan Res. 2017; 10:1178646917710668.
    View in: PubMed
    Score: 0.180
  26. Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients. Immun Inflamm Dis. 2017 09; 5(3):244-260.
    View in: PubMed
    Score: 0.178
  27. Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19. Front Immunol. 2021; 12:708149.
    View in: PubMed
    Score: 0.060
  28. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021 08; 16(5):1231-1237.
    View in: PubMed
    Score: 0.060
  29. Comparison Between Hospitalized Patients Affected or Not Affected by Coronavirus Disease 2019. Clin Infect Dis. 2021 06 15; 72(12):e1158-e1159.
    View in: PubMed
    Score: 0.059
  30. Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review. Int J Environ Res Public Health. 2021 01 12; 18(2).
    View in: PubMed
    Score: 0.058
  31. Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19). Virus Res. 2021 04 02; 295:198283.
    View in: PubMed
    Score: 0.058
  32. Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb Haemost. 2021 01; 121(1):102-105.
    View in: PubMed
    Score: 0.058
  33. Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization. Infez Med. 2020 Dec 01; 28(4):534-538.
    View in: PubMed
    Score: 0.057
  34. Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial. J Med Virol. 2021 04; 93(4):2210-2220.
    View in: PubMed
    Score: 0.057
  35. Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep. 2020 10 15; 10(1):17419.
    View in: PubMed
    Score: 0.057
  36. Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
    View in: PubMed
    Score: 0.056
  37. Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19. Circ Res. 2020 07 17; 127(3):400-401.
    View in: PubMed
    Score: 0.055
  38. HIV-2 Infection in a Migrant from Gambia: The History of the Disease Combined with Phylogenetic Analysis Revealed the Real Source of Infection. AIDS Res Hum Retroviruses. 2018 12; 34(12):1090-1094.
    View in: PubMed
    Score: 0.049
  39. Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation. J Immunol Res. 2018; 2018:1738676.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.